Create Account
B
Amgen Inc.
AMGN
NASDAQ
$248.39 $0.040.02% Volume3,461,117 08/12/2022 4:00PM Eastern Quotes delayed
Recommendation
Buy
Prev Close
$248.39
Avg Vol (90D)
3,076,758
Market Cap
$132.87B
Dividend & Yield
$7.40(2.98%)
52-Week Range
$198.64 - $258.45
P/E (TTM)
21.05
EPS (TTM)
$11.80
My Lists My Alerts
Report
Rating
Reward
B+
Good
Risk
C+
Fair
Rating Factors
Growth Index
Good
Efficiency Index
Excellent
Solvency Index
Good
Total Return Index
Fair
Volatility Index
Fair
Dividend Index
Good
Headlines
Bank of Nova Scotia Cuts Stake in Amgen Inc. (NASDAQ:AMGN)
8/13/2022 - Zolmax
Just Three Days Till Amgen Inc. (NASDAQ:AMGN) Will Be Trading Ex-Dividend
8/13/2022 - Simply Wall St
Duality Advisers LP Sells 1,996 Shares of Amgen Inc. (NASDAQ:AMGN)
8/13/2022 - Ticker Report
Research Analysts Set Expectations for Amgen Inc.'s Q4 2022 Earnings (NASDAQ:AMGN)
8/13/2022 - Ticker Report
$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
8/12/2022 - Benzinga
Senate Finance Committee Expands Amgen's Tax Probe: Report
8/12/2022 - Benzinga
GW&K Investment Management LLC Has $97,000 Stock Position in Amgen Inc. (NASDAQ:AMGN)
8/12/2022 - Zolmax
The Zacks Analyst Blog Highlights Amgen, ChemoCentryx, Mersana Therapeutics, GSK and Vertex Pharmaceuticals
8/12/2022 - Zacks Investment Research
Amgen under fire from Sen. Wyden over tax practices - Reuters
8/11/2022 - Seeking Alpha - Healthcare
Amgen: ChemoCentryx Buyout Papers Over Cracks In Long-Term Outlook
8/11/2022 - Seeking Alpha - Healthcare
3 Best Funds for Aggressive Investors
8/11/2022 - InvestorPlace
Senate Finance Committee looks at Amgen taxes, widening drugmaker probe
8/11/2022 - Financial Post
4 Index Funds to Buy and Hold Forever
8/11/2022 - InvestorPlace
Biotech Stock Roundup: AMGN's Q2 Earnings, CCXI AcquisitionMore Updates
8/11/2022 - Zacks Investment Research
Csenge Advisory Group Has $534,000 Stock Position in Amgen Inc. (NASDAQ:AMGN)
8/11/2022 - Ticker Report
SVB Leerink Equities Analysts Cut Earnings Estimates for Amgen Inc. (NASDAQ:AMGN)
8/11/2022 - Ticker Report
Atlantic Securities Cuts Amgen (NASDAQ:AMGN) Price Target to $182.00
8/11/2022 - Ticker Report
Does CPI Signal Slowing Inflation? Analysts Upgrade or Downgrade RealReal, Twilio, Vertex Energy and More
8/10/2022 - 24/7 Wall St.
Wednesday's Top Analyst Upgrades and Downgrades: Amgen, Coinbase, Micron Technology, Nvidia, Roku, Take-Two Interactive and More
8/10/2022 - 24/7 Wall St.
Amgen a Top Socially Responsible Dividend Stock With 3.1% Yield (AMGN)
8/10/2022 - ETF Channel
Why Amgen is a Top 25 Dividend Giant (AMGN)
8/10/2022 - ETF Channel
FY2022 EPS Estimates for Amgen Inc. (NASDAQ:AMGN) Raised by Analyst
8/10/2022 - Ticker Report
Amgen (NASDAQ:AMGN) Downgraded by StockNews.com to "Buy"
8/10/2022 - Ticker Report
This Is What Whales Are Betting On Amgen
8/9/2022 - Benzinga
Is Amgen (NASDAQ:AMGN) A Risky Investment?
8/9/2022 - Simply Wall St
Income Statement
Total Revenue (TTM)
$26.38B
EBITDA (TTM)
$12.63B
EBIT (TTM)
$9.41B
Net Income (TTM)
$6.58B
Balance Sheet
Total Assets (Q)
$59.29B
Total Debt (Q)
$36.52B
Total Liabilities (Q)
$56.88B
Book Value Per Share (Q)
$4.52
Cash Flow
Cash from Operations (TTM)
$9.32B
Cash from Investing (TTM)
-$2.46B
Cash from Financing (TTM)
-$8.29B
Net Change in Cash (TTM)
-$1.43B
Filings
Filing Date
Friday, August 5, 2022
Period Date
Thursday, June 30, 2022
Next Filing
Beginning of November (est)
Price History
Loading...
Beta
0.38
7-Day Total Return
0.57%
30-Day Total Return
1.16%
60-Day Total Return
1.82%
90-Day Total Return
1.58%
Year to Date Total Return
9.73%
1-Year Total Return
8.42%
2-Year Total Return
3.50%
3-Year Total Return
22.39%
5-Year Total Return
51.75%
52-week Low
Dec 01, 2021 - $198.64
52-week High
Apr 11, 2022 - $258.45
Valuation
Market Cap
$132.87B - Large Cap
Enterprise Value
$162.21B
Price/Sales (TTM)
5.06
Price/Book (Q)
54.93
Dividends and Shares
Shares Outstanding
537.00M
Dividend Per Share (Most Recent)
$1.94
Dividend Per Share (TTM)
$7.40
Corporate Info
Website
www.amgen.com
Phone Number
805 447 1000
Address
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Country
United States
Year Founded
1980
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and... more
Weiss Ratings